Customers
BHI Stem Cells has documented more than 4,000 stem cell research procedures. Its cellular products are investigational and are not offered as a treatment for any disease.
Research
BHI Stem Cells has conducted clinical investigations in collaboration with local partners in Slovakia and China, to study adult stem cells in regenerative medicine research. These cellular products are investigational and have not been shown to be safe or effective for any disease or condition.
Safety
In the clinical studies we have taken every precaution to ensure the safety and viability of adult stem cells administered. The clinical studies are part of ongoing investigational research into adult stem cells
